+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition of neuroblastoma-induced angiogenesis by fenretinide



Inhibition of neuroblastoma-induced angiogenesis by fenretinide



European Journal of Cancer 37(Suppl. 6): S263



Retinoids are a class of natural or synthetic compounds that participate in the control of cell proliferation, differentiation and fetal development. The synthetic retinoid fenretinide (HPR) inhibits carcinogenesis in various animal models. Retinoids have also been suggested to be effective inhibitors of angiogenesis. The effects of HPR on certain endothelial cell functions were investigated in vitro, and its effects on angiogenesis was studied in vivo, by using the chorioallantoic membrane (CAM) assay. HPR inhibited vascular endothelial growth factor- (VEGF-) and fibroblast growth factor-2- (FGF-2)-induced endothelial cell proliferation without affecting endothelial motility; moreover, HPR inhibited growth factor-induced angiogenesis in the CAM assay. Furthermore, a significant antiangiogenic potential of HPR has also been observed in neuroblastoma (NB) biopsy-induced angiogenesis in vivo. We previously demonstrated that supernatants derived from NB cell lines stimulated endothelial cell proliferation. In the present study, we found that this effect was abolished when NB cells were incubated in the presence of HPR. VEGF- and FGF-2-specific ELISA assays, performed on both NB cells derived from conditioned medium and cellular extracts, indicated no consistent effect of HPR on the level of these angiogenic cytokines. Moreover, RT-PCR analysis of VEGF and FGF-2 gene expression confirmed the above lack of effect. HPR was also able to significantly repress the spontaneous growth of endothelial cells, requiring at least 48-72 hr of treatment with HPR, followed by a progressive accumulation of cells in G1 at subsequent time points. Finally, immunohistochemistry experiments performed in the CAM assay demonstrated that endothelial staining of both VEGF receptor 2 and FGF-2 receptor-2 was reduced after implantation of HPR-loaded sponges, as compared to control CAMs. These data suggest that HPR exerts its antiangiogenic activity through both a direct effect on endothelial cell proliferative activity and an inhibitory effect on the responsivity of the endothelial cells to the proliferative stimuli mediated by angiogenic growth factors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010850493

Download citation: RISBibTeXText

PMID: 11745408

DOI: 10.1002/ijc.1441


Related references

Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer ChemoTherapy and Pharmacology 62(4): 655-665, 2008

Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastoma. Molecular Pharmacology 64(6): 1370-1378, 2003

P75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma. Cancer ChemoTherapy and Pharmacology 73(2): 271-279, 2014

Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Experimental Cell Research 260(1): 50-60, 2000

The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Cancer Letters 228(1-2): 105-110, 2005

Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells. Annals of the new York Academy of Sciences 1028: 81-89, 2004

GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Research 62(18): 5158-5167, 2002

Apoptosis of human neuroblastoma cells induced by liposome-encapsulated fenretinide. Journal of Liposome Research 8(3): 401-423, 1998

Induction of GADD153 and Bak: Novel molecular targets of fenretinide-induced apoptosis of neuroblastoma. Cancer Letters 197(1-2): 157-163, 2003

Bak: a downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cells. Cancer Research 63(21): 7310-7313, 2003

Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma. Bmc Cancer 9: 97, 2009

Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma. Journal of Cellular Biochemistry 89(4): 698-708, 2003

The NF-kappaB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells. Apoptosis 10(3): 493-498, 2005